tetraphenylphosphonium has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danik, SB; Elmaleh, DR; Gewirtz, H; Gurm, GS; Laferrier, S; Shoup, TM; Takahashi, K; Weise, S | 1 |
| Schöder, H; Strauss, HW | 1 |
2 other study(ies) available for tetraphenylphosphonium and Coronary Artery Disease
| Article | Year |
|---|---|
4-[18F]-tetraphenylphosphonium as a PET tracer for myocardial mitochondrial membrane potential.
Topics: Animals; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Disease Models, Animal; Hemodynamics; Humans; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardial Perfusion Imaging; Myocardium; Onium Compounds; Organophosphorus Compounds; Oximetry; Positron-Emission Tomography; Radiopharmaceuticals; Sus scrofa | 2012 |
Myocardial imaging for mitochondrial membrane potential.
Topics: Animals; Coronary Artery Disease; Humans; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardial Perfusion Imaging; Onium Compounds; Organophosphorus Compounds; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |